Elevate Ventures — 2023 Investments
13 investments dated 2023 · listed companies and verified rows first · show all
Bereave provides technology that helps people find guidance, support and information when navigating the death of a loved one, serving employees, families, HR teams and managers.
Future of WorkHR TechSaaSWellness & FitnessIndianapolis, US
Kristine Camron(Executive Officer)Justin Clifford(CEO)
BoardMike Trotzke(Director)Michelle Cole(Director)Elijah Linder(Director)
Board seatMatt Tyner· per SEC Form D · $327.7K raise · filed Aug 2024
Co-investorsIU Ventures
AfterSchool HQ operates a platform that connects students with after-school programs to help them explore interests and activities.
ConsumerEdTechEnterprise SoftwareMarketplacesSaaSFishers, US
San Pathak(COO & Co-Founder)inDarye Henry(CEO)inDareskedar Henry(Executive Officer, Director, Promoter)
BoardJennifer Carolan(Director)in
Co-investorsBlack Tech Nation VenturesSixty8 CapitalFlywheel FundReach Capital
Amplified Sciences is a clinical-stage diagnostics company that has developed an ultra-sensitive optical reporter platform for multi-omics diagnostic tests, aimed at helping clinicians detect, treat, and monitor difficult diseases.
BiotechHealthtechMedical DevicesWest Lafayette, US
Diana Caldwell(Executive Officer, Director)inVincent Jo Davisson(Executive Officer, Director)
BoardAndrew Cothrel(Director)inWade Lange(Director)Robert Saunders(Director)
Co-investorsBeni Venture CapitalGravity VenturesHouston Angel NetworkIU VenturesFlywheel FundOCA Ventures
Laxis provides an AI assistant integrated across Mac, Windows, and Web that captures and analyzes meeting insights, ensuring no idea is lost and every participant's voice is heard.
AI & Machine LearningEnterprise SoftwareFuture of WorkMarketing TechSaaSSales TechSan Francisco, US
Xiangning Liu(Founder)inEric Xiao(Founder & CEO, Laxis Inc.)in
Co-investorsCeltic House Asia PartnersGround Game VenturesAllos VenturesFlywheel FundLofty Ventures
NĒRx Biosciences develops small molecule inhibitors targeting DNA damage sensor proteins for cancer treatment, with initial focus on difficult-to-treat lung and ovarian cancers.
BiotechHealthtechMedical DevicesIndianapolis, US
John Turchi(Co-Founder, President and CSO)inNicholas Ball(CFO)Robert Feltgenin
Co-investorsIU Ventures
Plan Forward provides a dental membership plan platform that automates member billing, renewals, and patient notifications, and integrates with major practice management systems.
Digital HealthHealthtechSaaSWestfield, US
Megan Lohman(Executive Officer, Director)inJane Levy(Executive Officer, Director)
Co-investorsIU VenturesRevere Partners
Qualifi is a hiring platform that lets recruiters send pre-recorded, voice-based automated phone screens and collect on-demand candidate responses, with follow-up scheduling built in.
Future of WorkHR TechSaaSNoblesville, US
Darrian Mikell(CEO / Co-Founder)inDevyn Mikell(COO / Co-Founder)inDeSean Prentice(VP of Engineering / Co-Founder)in
Co-investorsBlue Trail PartnersDebut CapitalRally Ventures Management, LlcService Provider CapitalSixty8 CapitalTechstars+6 more
Fishers, US
Matthew J. Wainscott(Executive Officer)Brian Stasey(Executive Officer)inEmmanuel Colliot(Executive Officer)Matthew Wyatt(Executive Officer, Director)in
Stamus Networks develops Clear NDR, a network detection and response system built on the Suricata open-source engine that converts network traffic into security insights for security operations teams.
AI & Machine LearningCybersecurityData & InfrastructureEnterprise SoftwareIndianapolis, US
Peter Manev(Co-founder)inÉric Leblond(Co-founder & CTO)inRonda Schwartzkopf(Executive Officer, Director)Ken Gramley(CEO)in
BoardNick Mirchef(Director)Howard Smith(Director)in
Co-investorsFirst Analysis
Vital View Technologies has rebranded to PrīmSphera and directs visitors to its new website.
Ray Fraser(Founder)in
Co-investorsPier 70 Ventures
HealthtechZionsville, US
David A. Broecker(Executive Officer, Director)Joseph Broecker(Director)Michael Mirro(Director)Ioannis Pandelidis(Director)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
HeliponixHUMN Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







































